176 related articles for article (PubMed ID: 22720826)
41. Cervical cancer vaccination indications, efficacy, and side effects.
Bayas JM; Costas L; Muñoz A
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S11-4. PubMed ID: 18586311
[TBL] [Abstract][Full Text] [Related]
42. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(40):1382-4. PubMed ID: 21993342
[TBL] [Abstract][Full Text] [Related]
43. Women's sexual behavior. Population-based study among 65,000 women from four Nordic countries before introduction of human papillomavirus vaccination.
Jensen KE; Munk C; Sparen P; Tryggvadottir L; Liaw KL; Dasbach E; Nygård M; Kjaer SK
Acta Obstet Gynecol Scand; 2011 May; 90(5):459-67. PubMed ID: 21306319
[TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus vaccines.
Satyaprakash A; Creed R; Ravanfar P; Mendoza N
Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
[TBL] [Abstract][Full Text] [Related]
45. Human papillomavirus infection: an old disease, a new vaccine.
Giles M; Garland S
Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):180-5. PubMed ID: 16704468
[TBL] [Abstract][Full Text] [Related]
46. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
[TBL] [Abstract][Full Text] [Related]
47. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
Harper DM
Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
[TBL] [Abstract][Full Text] [Related]
48. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
49. Human papilloma virus vaccination for control of cervical cancer: a challenge for developing countries.
Bello FA; Enabor OO; Adewole IF
Afr J Reprod Health; 2011 Mar; 15(1):25-30. PubMed ID: 21987934
[TBL] [Abstract][Full Text] [Related]
50. Human papillomavirus (HPV) vaccine acceptance and perceived effectiveness, and HPV infection concern among young New Zealand university students.
Chelimo C; Wouldes TA; Cameron LD
Sex Health; 2010 Sep; 7(3):394-6. PubMed ID: 20719233
[TBL] [Abstract][Full Text] [Related]
51. Public health issues related to HPV vaccination.
Hershey JH; Velez LF
J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306
[TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus vaccines: an update for gynecologists.
Ault KA
Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
[TBL] [Abstract][Full Text] [Related]
53. Preparing for HPV vaccination in South Africa: key challenges and opinions.
Harries J; Moodley J; Barone MA; Mall S; Sinanovic E
Vaccine; 2009 Jan; 27(1):38-44. PubMed ID: 18977271
[TBL] [Abstract][Full Text] [Related]
54. Factors associated with intention-to-recommend human papillomavirus vaccination among physicians in Mysore, India.
Krupp K; Marlow LA; Kielmann K; Doddaiah N; Mysore S; Reingold AL; Madhivanan P
J Adolesc Health; 2010 Apr; 46(4):379-84. PubMed ID: 20307828
[TBL] [Abstract][Full Text] [Related]
55. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
[TBL] [Abstract][Full Text] [Related]
56. Epidemiology of mucosal human papillomavirus infection and associated diseases.
Trottier H; Burchell AN
Public Health Genomics; 2009; 12(5-6):291-307. PubMed ID: 19684442
[TBL] [Abstract][Full Text] [Related]
57. The pharmaceuticalization of sexual risk: vaccine development and the new politics of cancer prevention.
Mamo L; Epstein S
Soc Sci Med; 2014 Jan; 101():155-65. PubMed ID: 24560236
[TBL] [Abstract][Full Text] [Related]
58. The sexualization of the medical.
Segal JZ
J Sex Res; 2012; 49(4):369-78. PubMed ID: 22720829
[TBL] [Abstract][Full Text] [Related]
59. Human papillomavirus-Inequalities in disease prevention and the impact on racial, ethnic, sexual, and gender minorities.
Junejo MH; Sheikh UA
Pediatr Dermatol; 2021 Nov; 38 Suppl 2():170-173. PubMed ID: 34351009
[TBL] [Abstract][Full Text] [Related]
60. HPV vaccination unlikely to promote risky sexual behaviours.
Bagcchi S
Lancet Oncol; 2015 Mar; 16(3):e111. PubMed ID: 25683847
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
